BioSpace News Archive

Salarius Pharmaceuticals, Inc. announced the closing of its previously announced underwritten public offering of 5,130,390 shares of its common stock, including 669,181 shares sold pursuant to the exercise in full of the underwriters’ option to purchase additional shares, at the public offering price of $1.20 per share.

Pacific Biosciences of California, Inc. announced financial results for its second quarter ended June 30, 2020.

Surgalign Holdings, Inc. announced that it is changing its earnings release and conference call date for the second quarter 2020 as a result of a delay completing the financial statements due to the additional workload created by the recently completed sale of the OEM business.

CorMedix Inc., a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, announced that it will report its financial results for the second quarter ended June 30, 2020, after the market close on Monday, August 10, and will host a corporate update conference call at 4:30pm Eastern Time.

CymaBay Therapeutics, Inc. announced that it will host a conference call and live audio webcast on Monday, August 10, 2020 at 4:30 p.m. Eastern Time to discuss financial results for the second quarter and six months ended June 30, 2020 and to provide a business update.

Quest Diagnostics, the world’s leading provider of diagnostic information services, announced that it has completed its previously announced acquisition of its joint venture partners’ interests in Mid America Clinical Laboratories.

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, announced that it will report financial results for the second quarter ended June 30, 2020 on Monday, August 10, 2020 after the market close.

Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring system for people with diabetes, announced that it plans to release its second quarter 2020 financial results after market close on Monday, August 10, 2020.

Cryoport, Inc., a global leader in life sciences solutions, announced that the Company will report financial results for the second quarter ended June 30, 2020 on Thursday, August 6, 2020 after U.S. markets close.

Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, will report its second quarter 2020 financial results and corporate updates on Monday, August 10, 2020, before the open of the U.S. financial markets.